Advancing Immunopeptidomics: Highlights from the Boston Expert Session

Immunopeptidomics is rapidly transforming how we understand immune recognition and therapeutic discovery. Recently, Alithea Bio brought together leading experts in immunopeptidomics and HLA research for an in-depth scientific conference in Boston. This session explored how high-resolution profiling is paving the way for the next generation of neoantigen discovery and precision medicine.

Conference Attendees & Contributors

The conference brought together senior scientists from global pharmaceutical and biotechnology organizations. These industry leaders discussed the integration of mass spectrometry-based proteomics into clinical development environments.

Event Gallery: The Boston Session

Key Discussion Outcomes

A primary focus of the discussion was how data-driven platforms like HLA-Compass support deeper immune insights. For those who couldn’t attend, we have made our latest findings available in our technical whitepaper on allele coverage.